Background. The plasma concentration of 5-hydroxytryptamine (5-HT) in
diabetic patients is higher than that in normal subjects. Since recent
reports have demonstrated the presence of 5-HT2A receptor in glomerul
ar mesangial cells, it is possible that 5-HT may be involved in the de
velopment of diabetic nephropathy through the 5-HT2A receptor in mesan
gial cells. Because expansion of the glomerular mesangial lesion is a
characteristic feature of diabetic nephropathy, we examined the effect
of 5-HT on the production of type IV collagen by human mesangial cell
s. Methods. Human mesangial cells were incubated with 5-HT with or wit
hout 5-HT receptor antagonists, protein kinase C (PKC) inhibitor or tr
ansforming growth factor-beta (TGF-beta) antibody. Type IV collagen mR
NA and protein concentration in medium were measured by Northern blot
analysis and enzyme-linked immunosorbent assay (ELISA), respectively.
TGF-beta mRNA and bioactivity in the medium were measured by Northern
blot analysis and bioassay using mink lung epithelial cells, respectiv
ely. Results. 5-HT stimulated the production of type IV collagen by hu
man mesangial cells, which was inhibited by ketanserin and sarpogrelat
e hydrochloride, 5-HT2A receptor antagonists, but not by ondansetron,
a 5-HT3 receptor antagonist. 5-HT increased the bioactivities of both
active and total TGF-P. However, the 5-HT-enhanced production of type
IV collagen was completely inhibited by an anti-TGF-beta antibody. Fur
thermore, a PKC inhibitor, calphostin C, inhibited the 5-HT-induced in
crease in type IV collagen secretion, and the activity of membrane PKC
was increased by 5-HT. Phorbol ester activated type IV collagen produ
ction as well as active and total TGF-beta. Calphostin C completely in
hibited the 5-HT-enhanced activity of active TGF-beta, but did not inh
ibit exogenous TGF-beta-induced increase in type IV collagen secretion
. Conclusions. Our results suggest that 5-HT-enhanced production of ty
pe TV collagen by human mesangial cells is mediated by activation of P
KC and subsequent increase in active TGF-beta activity.